Study of the diagnostic yield of cytology in pleural fluid in malignant pleural effusions in Tishreen University Hospital.

Authors

  • Leen Adrah Tishreen University
  • Mohammad Alkhayer Tishreen University
  • Rana Essa Tishreen University

Abstract

Background: Malignant pleural effusion (MPE) is a common global issue, resulting from direct invasion of the pleura by adjacent tumors or secondary to pleural metastases. Not all pleural effusions in patients with cancer are malignant, thus accurate diagnosis is crucial as it influences prognosis and treatment. Various methods are employed to diagnose effusions, with cytology being an initial investigation due to its relatively non-invasive nature. The diagnostic accuracy of cytology for MPE ranges between 40-87%.

Objective: To evaluate the diagnostic value of cytology of pleural fluid in malignant pleural effusions at Tishreen University Hospital, and to classify the most common tumors causing malignant pleural effusion as diagnosed by cytology.

Methods: The study included 85 patients: those with previously diagnosed tumors who developed pleural effusion for the first time, and patients who presented with pleural effusion for the first time with clinical or radiological suspicion of a tumor and were subsequently diagnosed. Pleural fluid samples were obtained via thoracentesis and sent for cytological examination. If the initial thoracentesis was negative, a second thoracentesis was performed in some patients.

Results: The diagnostic value of cytology was 50.6%. The diagnostic yield was 40% on the first thoracentesis, and repeating the procedure improved the diagnostic value by 10.6%. The most frequently diagnosed  type was adenocarcinoma, accounting for 74.4%.

Conclusion: Cytology is an important and useful initial investigation for diagnosing malignant pleural effusion. The diagnostic value improves with repeated thoracentesis, and the type of tumor plays a significant role in the cytological diagnosis.

Downloads

Published

2024-11-13

How to Cite

1.
عدره ل, محمد الخير, رنا عيسى. Study of the diagnostic yield of cytology in pleural fluid in malignant pleural effusions in Tishreen University Hospital. Tuj-hlth [Internet]. 2024Nov.13 [cited 2024Nov.20];46(4):571-82. Available from: https://journal.tishreen.edu.sy/index.php/hlthscnc/article/view/18063

Issue

Vol. 46 No. 4 (2024): Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

Section

Master student researches

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

 Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series   .  The Readers have the right to send, print and subscribe to the initial version of the article, and the title of  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series  Publisher

journal uses a CC BY-NC-SA license which mean

You are free to:

  • Adapt — remix, transform, and build upon the material
  •  
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

 

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.